BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16109051)

  • 1. Calcitonin gene-related peptide in cervicogenic headache.
    Frese A; Schilgen M; Edvinsson L; Frandsen E; Evers S
    Cephalalgia; 2005 Sep; 25(9):700-3. PubMed ID: 16109051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No increase of calcitonin gene-related peptide in jugular blood during migraine.
    Tvedskov JF; Lipka K; Ashina M; Iversen HK; Schifter S; Olesen J
    Ann Neurol; 2005 Oct; 58(4):561-8. PubMed ID: 16178016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache.
    Ashina M; Bendtsen L; Jensen R; Schifter S; Jansen-Olesen I; Olesen J
    Neurology; 2000 Nov; 55(9):1335-40. PubMed ID: 11087777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine levels in the jugular venous blood of migraine without aura patients during attacks.
    Sarchielli P; Alberti A; Vaianella L; Pierguidi L; Floridi A; Mazzotta G; Floridi A; Gallai V
    Headache; 2004; 44(10):961-8. PubMed ID: 15546258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of cAMP, cGMP and CGRP in sildenafil-induced headache.
    Kruuse C; Frandsen E; Schifter S; Thomsen LL; Birk S; Olesen J
    Cephalalgia; 2004 Jul; 24(7):547-53. PubMed ID: 15196297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
    Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
    Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache.
    Alessandri M; Massanti L; Geppetti P; Bellucci G; Cipriani M; Fanciullacci M
    Cephalalgia; 2006 Nov; 26(11):1287-93. PubMed ID: 17059435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack.
    Juhasz G; Zsombok T; Jakab B; Nemeth J; Szolcsanyi J; Bagdy G
    Cephalalgia; 2005 Mar; 25(3):179-83. PubMed ID: 15689192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
    Bellamy JL; Cady RK; Durham PL
    Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers.
    Kruuse C; Iversen HK; Jansen-Olesen I; Edvinsson L; Olesen J
    Cephalalgia; 2010 Apr; 30(4):467-74. PubMed ID: 19673898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype.
    Hansen JM; Thomsen LL; Olesen J; Ashina M
    Neurology; 2008 Sep; 71(11):841-7. PubMed ID: 18779512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.
    Goadsby PJ; Edvinsson L; Ekman R
    Ann Neurol; 1988 Feb; 23(2):193-6. PubMed ID: 2454066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
    Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
    Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine.
    Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC
    Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.
    Sarchielli P; Pini LA; Zanchin G; Alberti A; Maggioni F; Rossi C; Floridi A; Calabresi P
    Cephalalgia; 2006 Mar; 26(3):257-65. PubMed ID: 16472331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin gene-related peptide levels are elevated in patients with sepsis.
    Joyce CD; Fiscus RR; Wang X; Dries DJ; Morris RC; Prinz RA
    Surgery; 1990 Dec; 108(6):1097-101. PubMed ID: 2247835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
    Goadsby PJ; Edvinsson L
    Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
    Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
    J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological markers of cervicogenic headache.
    Frese A; Evers S
    Cephalalgia; 2008 Jul; 28 Suppl 1():21-3. PubMed ID: 18494989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.